Prof. Xueji Li 李学记
Chief Physician, Professor
Department of Neurosurgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Microscopic and endoscopic neurosurgery for high-risk skull base and intracranial tumors, aneurysms, vascular malformations, spinal cord tumors, and meningiomas. Reported surgical complication rate is under 1%.
Dr. Li holds a PhD in Neurosurgery and serves as Director of Neurosurgery at the Hebei Hospital of Cancer Hospital, Chinese Academy of Medical Sciences. Since 1992, Dr. Li has performed over 5,000 microsurgical and endoscopic procedures for central nervous system tumors. Research includes multiple national projects, 46 papers, five monographs, two utility patents, and provincial and municipal science and technology awards.
Name order: in Chinese the family name comes first (Li Xueji). Papers usually list the name as Xueji Li or Li X.
Selected publications
12 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- 3D Print Med, 2025 (first author): Enhancing skull base tumor management: the combination of 3D printing technology and endoscopic surgical techniques. PubMed 40504428
- World Neurosurg, 2024 (senior author): Adult Central Neurocytomas: Clinical Features and Long-Term Treatment Outcomes in Different Age Groups. PubMed 38604535
- Childs Nerv Syst, 2023 (senior author): Pediatric atypical extraventricular neurocytoma: Clinical features and survival outcomes. PubMed 37326845
- Childs Nerv Syst, 2023 (senior author): Central neurocytomas in children: Clinicopathologic features and long-term surgical outcomes. PubMed 36094604
- Comput Intell Neurosci, 2022 (senior author): A Potential Prognostic Biomarker for Glioma: Aldo-Keto Reductase Family 1 Member B1. PubMed 35341178
- J Cancer Res Ther, 2019 (senior author): Anticancer effects of FL34 through the inhibition of GLI1 in glioblastoma. PubMed 31436248
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion